10 completed, 3 recruiting, 3 unknown, 2 withdrawn. 14 Not applicable, 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 14 | Completed 8, Recruiting 2, Active not recruiting 1, Terminated 1, Unknown 1, Withdrawn 1 |
| Phase 3 | 2 | Completed 1, Unknown 1 |
| Phase 2 | 1 | Unknown 1 |
Follow this drug Literature Review of Vaginal Smears trials Research Report on Vaginal Smears
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Serous Endometrial Intraepithelial Carcinoma (SEIC): Prospective Registration Study Blood sample (serum) for circulating tumor DNA and cervical smear for genome-wide methylation sequencing - Serous Endometrial Intraepithalial Carcinoma, SEIC | Not yet recruiting | Erasmus Medical Center | 100 | 2025-04-01 | 2025-02-10 | |
| Prevalence of HPV (Human Papilloma Virus) and HPV Vaccination Among Victims of Sexual Violence smears - Human Papilloma Virus, Sexual Assault | Unknown | Centre Hospitalier Universitaire Saint Pierre | 200 | 2024-02-01 | 2024-02-13 | |
| Clinical Trial of "Magic Gyno" Laser Device Laser treatment, Blood test, Clinical urine test - Female Urogenital Diseases, Urinary Incontinence | Not applicable | Completed | MeLSyTech, Ltd | 70 | 2022-08-05 | 2024-12-10 |
| Treatment of Vaginal Atrophy With Low Intensity Nanosecond Neodymium Laser Laser Treatment, Topical hormone estriol, Сlinical blood analysis - Postmenopausal Period, Vaginal Atrophy | Not applicable | Recruiting | MeLSyTech, Ltd | 120 | 2022-04-18 | 2024-12-12 |
| Pelvic Organs Prolapse Treatment Using Neodymium Laser Laser Treatment, Blood analysis, Сlinical urine test - Pelvic Organ Prolapse, Female Urogenital Diseases | Not applicable | Active not recruiting | MeLSyTech, Ltd | 129 | 2021-10-03 | 2024-12-12 |
| Vulvovaginal Atrophy Correction Using Neodymium Laser Laser Treatment, Topical hormone estriol, Сlinical blood analysis - Postmenopausal Period, Vaginal Atrophy | Not applicable | Completed | MeLSyTech, Ltd | 120 | 2021-09-01 | 2024-12-12 |
| Papillomavirus Load in Rheumatic Inflammatory Diseases Cervical smear, Pregnancy test, Sexual activity questionnary - Spondyloarthritis, Rhumatoid Arthisis | Not applicable | Unknown | Hospices Civils de Lyon | 385 | 2020-01-09 | 2021-07-27 |
| Determine the Utility of Liquid Biopsies and Tumor Molecular Profiling in Predicting Recurrence in Endometrial Cancers Biospecimen Collection, Liquid Biopsy, Pap Smear - Endometrial Clear Cell Adenocarcinoma, Endometrial Dedifferentiated Carcinoma | Recruiting | M.D. Anderson Cancer Center | 1000 | 2019-06-18 | 2026-10-07 | |
| Lavage of the Uterine Cavity for Diagnosis of Ovarian Cancer Biospecimen Collection, Laboratory Biomarker Analysis, Lavage - High Grade Ovarian Serous Adenocarcinoma, Stage III Ovarian Cancer AJCC v8 | Not applicable | Terminated | University of Washington | 52 | 2018-11-16 | 2024-01-17 |
| Automated Cervical Cancer Screening Using a Smartphone-based Artificial Intelligence Classifier AVC test - Cervical Cancer, HPV | Not applicable | Recruiting | Prof. Patrick Petignat | 5886 | 2018-08-01 | 2025-01-29 |
| Self-Sampling for Human Papillomavirus (HPV) Testing in African American Women - Mississippi Delta Pap testing, Choice - Cervical Cancer | Not applicable | Completed | University of Alabama at Birmingham | 335 | 2016-11-28 | 2022-11-16 |
| Self-Collection and Human Papillomavirus (HPV) Testing in Unscreened Women: a Feasibility Study in Brazil Pap testing, Self-collection for HPV testing, Choice - Cervical Cancer | Not applicable | Completed | University of Alabama at Birmingham | 484 | 2016-01-01 | 2018-10-22 |
| Home-Based or Clinic-Based Human Papillomavirus (HPV) Screening Cervical Papanicolaou Test, Cytology Specimen Collection Procedure, Questionnaire Administration - Atypical Squamous Cell of Undetermined Significance, Cervical Carcinoma | Not applicable | Completed | University of Washington | 1335 | 2012-03-01 | 2020-07-31 |
| Vulvar Contact Dermatitis Resulting From Urine Incontinence Questionnaires, gynecological exam , vaginal smear, and measurement of urine leakage - Urinary Incontinence, Vulvar Pruritus | Withdrawn | Meir Medical Center | 2011-03-01 | 2015-04-08 | ||
| Randomized Trial of Vaginal Self Sampling for Human Papillomavirus (HPV) offer of vaginal self collection, 2nd reminder letter for Pap testing - Human Papillomavirus Infection, Cervical Intraepithelial Neoplasia | Phase 2 / Phase 3 | Unknown | McMaster University | 1440 | 2010-04-01 | 2011-07-21 |
| Self-Sampling in Women Who Do Not Undergo Routine Cervical Screening compliance monitoring, cervical Papanicolaou test, educational intervention - Health Status Unknown, Precancerous Condition | Completed | Barts and the London School of Medicine and Dentistry | 3000 | 2009-06-01 | 2013-08-07 | |
| Matrix Metalloproteinases and Human Papillomavirus in Dysplasias and Cancers of the Cervix Vaginal samples (biopsies + vaginal smear) - Papillomavirus Infections, Dysplasia | Not applicable | Completed | University Hospital, Bordeaux | 216 | 2007-10-10 | 2026-06-24 |
| Identification and Impact of Vaginal Flora Anomalies Among Pregnant Woman cervical smear - Vaginosis, Bacterial | Not applicable | Completed | Assistance Publique Hopitaux De Marseille | 1000 | 2007-07-01 | 2014-08-28 |
| Diindolylmethane in Treating Patients With Abnormal Cervical Cells oral microencapsulated diindolylmethane, polymerase chain reaction, cervical Papanicolaou test - Cervical Cancer, Precancerous Condition | Phase 3 | Completed | Barts and the London School of Medicine and Dentistry | 3000 | 2004-10-01 | 2013-08-07 |
| Protein Expression as a Potential Diagnostic Biomarker of Cervical Dysplasia and/or Cancer Cervical Papanicolaou Test, Conization, Laboratory Biomarker Analysis - Precancerous Condition, Stage 0 Cervical Cancer | Not applicable | Completed | Gynecologic Oncology Group | 684 | 1998-09-01 | 2015-05-29 |
Showing 20 of 21. Sign in to see all of them.
Uterine Cervical Neoplasms (7) · Papillomavirus Infections (5) · Uterine Cervical Dysplasia (5) · Female Urogenital Diseases (3) · Precancerous Conditions (3) · Pelvic Organ Prolapse (2) · Urinary Incontinence (2) · Uterine Prolapse (2) · Atypical Squamous Cells of the Cervix (1) · Endometrial Neoplasms (1) · Neoplasms (1) · Ovarian Neoplasms (1) · Pruritus Vulvae (1) · Sexual Dysfunction, Physiological (1) · Spondylarthritis (1)
MeLSyTech, Ltd (4) · Barts and the London School of Medicine and Dentistry (2) · University of Alabama at Birmingham (2) · University of Washington (2) · Assistance Publique Hopitaux De Marseille (1) · Centre Hospitalier Universitaire Saint Pierre (1) · Erasmus Medical Center (1) · Gynecologic Oncology Group (1) · Hospices Civils de Lyon (1) · M.D. Anderson Cancer Center (1) · McMaster University (1) · Meir Medical Center (1) · Northwestern University (1) · Prof. Patrick Petignat (1) · University Hospital, Bordeaux (1)
United States (5) · Russia (4) · France (3) · United Kingdom (2) · Brazil (1) · Cameroon (1) · Canada (1) · Israel (1) · Netherlands (1)
Alice Lytwyn, MD, FRCPC (1) · Amy Halverson (1) · Anne Szarewski, MD (1) · Barbara S. Norquist (1) · Charlotte Rousseau, Dr (1) · Gennadij O Grechkanev, M.D. (1) · Heleen J. van Beekhuizen (1) · Inna A Apolikhina, Ph.D. (1) · Isabel C Scarinci, PhD (1) · Isabel C. Scarinci, PhD (1) · Liya Z Sirotina (1) · Nancy Kiviat (1)
PMID 20027045, PMID 21789604, PMID 25452591, PMID 28332888, PMID 30651294, PMID 31264912, PMID 33338505, PMID 34914727, PMID 42567642
2017 (1), P30CA013148 (1), R01CA157469 (1)